Filing Details
- Accession Number:
- 0001477932-19-003932
- Form Type:
- 13D Filing
- Publication Date:
- 2019-07-08 09:20:07
- Filed By:
- Gordon Sean
- Company:
- Eterna Therapeutics Inc. (NYSEMKT:ERNA)
- Filing Date:
- 2019-07-08
- SEC Url:
- 13D Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Sean Gordon | 200,222 | 0 | 200,222 | 0 | 200,222 | 7% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934 (Amendment No. 1)
NTN Buzztime, Inc. |
(Name of Issuer) |
Common Stock |
(Title of Class of Securities) |
629410606 |
(CUSIP Number) |
The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, Wilmington, DE 19801, 302-658-7581 |
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
|
July 8, 2019 |
(Date of Event which Requires Filing of this Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d-7(b) for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
SCHEDULE 13D/A
CUSIP No. | 629410606 |
|
1 | NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Sean Gordon | |||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) x | |||
3 | SEC USE ONLY
| |||
4 | SOURCE OF FUNDS (See Instructions)
PF | |||
5 | CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
¨ | |||
6 | CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 7 | SOLE VOTING POWER
200,222 |
8 | SHARED VOTING POWER
0 | |
9 | SOLE DISPOSITIVE POWER
200,222 | |
10 | SHARED DISPOSITIVE POWER
0 |
11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
200,222 | |||
12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
¨ | |||
13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7% | |||
14 | TYPE OF REPORTING PERSON (See Instructions)
IN |
2 |
Item 1. Security and Issuer
Item 1 is hereby amended as follows:
This Statement on Schedule 13D/A (this “Schedule 13D/A”) relates to the Common Stock par value of $0.005 of NTN Buzztime, Inc. (the “Issuer”) with its principal executive office located at 1800 Aston Avenue, Suite # 100, Carlsbad, CA 92008.
Item 2. Identity and Background
No change.
Item 3. Source and Amount of Funds or Other Considerations
Item 3 is hereby amended as follows:
From January 25, 2018 to July 2, 2019, the Reporting Person sold and purchased shares of the outstanding Common Stock of the Issuer by transactions on open market at the current market prices on the date of such transactions. The Reporting Person acquired the Common Stock with personal funds. No borrowed funds were used to purchase the Common Stock.
Item 4. Purpose of Transaction
Item 4 is hereby supplemented by adding the following:
Adding to concerns with the Issuer’s sales strategies and declining stock price, the Reporting Person is attaching a new Note regarding the Issuer’s recent 2019 annual shareholder meeting. This is supplemental to the letter sent to the Board of Directors of the Issuer on January 24, 2018, in addition to the Reporting Person taking such actions including purchasing additional shares and selling some shares based on his concerns and review on the investment in the Issuer. The note from the Reporting Person regarding the results of the Issuer’s 2019 annual shareholder meeting, the 2018 letter from the Reporting Person to the Board of Directors of the Issuer, and the 2018 follow-up letter are hereby attached as Exhibit 99.1, Exhibit 99.2, and Exhibit 99.3.
The Reporting Person intends to review his investment in the Issuer on a continuing basis and may engage in discussions with the Issuer’s Board of Directors and/or management, other stockholders of the Issuer, and/or other relevant parties concerning the Issuer’s business, corporate governance, management and future plans. The Reporting Person may take such actions in the future with respect to his investment in the Issuer as he deems advisable including, without limitation, purchasing additional shares of Common Stock or selling some or all of his shares, engaging in short selling of or any hedging or similar transactions with respect to the shares, and/or otherwise changing his intention with respect to the matters referred to in this Item 4 of Schedule 13D. Such actions will depend upon various factors including, without limitation, the Issuer’s financial and strategic direction and position, the response of the Board of Directors to the proposal referred to above, the price performance of the Issuer’s shares, general conditions in the Issuer’s industry, the economy and the securities markets, and the availability of other investment opportunities.
With the sole exception of (d) of Item 4 of Schedule 13D, relating to a proposed change in the present board of directors or management of the Issuer, the Reporting Person does not have any present plans or proposals that relate to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. At any time and from time to time, the Reporting Person may review, reconsider and change his position and/or change his purpose and/or develop such plans or proposals.
3 |
Item 5. Interest in Securities of the Issuer
Item 5 is hereby amended as follows:
| (a) | The Reporting Person is the beneficial owner of 200,222 Shares of Common Stock par value of $0.005, or 7.00% of the total issued and outstanding Common Stock, based on 2,878,096 shares of the Issuer’s Common Stock outstanding as of March 31,2019, as reported in the Issuer’s Form 10-Q for the quarter ended March 31, 2019. |
|
|
|
| (b) | The number of Shares of Common Stock beneficially owned by the Reporting Person and, the number of Shares of Common Stock as to which there is sole power to vote or to direct the vote, and the number of Shares of Common Stock as to which there is the sole power to dispose or to direct the disposition is 200,222. |
|
|
|
| (c) | The Reporting Person has conducted the following transactions in the class of securities described herein within the past sixty (60) days: |
Person who effected the transaction |
| Date |
| Transaction |
| Amount of Securities involved |
|
| Price per share | ||
Sean Gordon |
| 7/2/19 |
| Buy |
|
| 222 |
|
| $3.79 | |
Sean Gordon |
| 6/14/19 |
| Sell |
|
| 501 |
|
| $3.42 | |
Sean Gordon |
| 5/15/19 |
| Buy |
|
| 1 |
|
| $2.54 |
| (d) | Not applicable. |
|
|
|
| (e) | Not applicable. |
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
No change.
Item 7. Material to Be Filed as Exhibits
Exhibit No. |
| Description |
| ||
|
|
|
| ||
|
|
|
| Letter from Mr. Sean Gordon regarding the business of NTN Buzztime, Inc., dated March 26, 2018. |
4 |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: July 8, 2019 | /s/ Sean Gordon | |
| Sean Gordon |
The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.
Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).
5 |